CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Randomized, Open, Phase III Trial of ddEC-THP（Epirubicin，Cyclophosphamide，TAX(Taxol)，Trastuzumab，Pertuzumab）vs Evaluating the Efficacy and Safety of TCHP （CBP(Carboplatin),TXT(Taxotere),Trastuzumab，Pertuzumab）Neoadjuvant Therapy for HER2-positive Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05871918
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:09.194820+00:00
Published At: 2023-05-23T00:00:00+00:00
Record Updated At: 2023-05-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["HER-2 Positive Breast Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-05-23"
protocolSection.identificationModule.nctId: "NCT05871918"
protocolSection.identificationModule.officialTitle: "A Multicenter, Randomized, Open, Phase III Trial of ddEC-THP\uff08Epirubicin\uff0cCyclophosphamide\uff0cTAX(Taxol)\uff0cTrastuzumab\uff0cPertuzumab\uff09vs Evaluating the Efficacy and Safety of TCHP \uff08CBP(Carboplatin),TXT(Taxotere),Trastuzumab\uff0cPertuzumab\uff09Neoadjuvant Therapy for HER2-positive Breast Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.